Trials / Unknown
UnknownNCT02059772
Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema
Evaluation of an Additional Therapeutic Approach to Diabetic Macular Edema by Combining Standard Therapy (Intravitreal Injection of a VEGF-inhibitor) With Micropulse Diode Laser Treatment in a Randomized, Controlled Proof of Concept Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- GWT-TUD GmbH · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate if a combination therapy with micropulse diode laser treatment shows non inferiority on visual acuity within 12 months in comparison to standard therapy (intravitreal injection of ranibizumab only).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ranibizumab | |
| PROCEDURE | micropulse diode laser |
Timeline
- Start date
- 2014-04-30
- Primary completion
- 2017-11-01
- Completion
- 2017-12-31
- First posted
- 2014-02-11
- Last updated
- 2017-02-23
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02059772. Inclusion in this directory is not an endorsement.